- Home
- GNRC vs RGEN Comparison
GNRC vs RGEN Comparison
Compare GNRC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNRC
- RGEN
- Stock Information
- Founded
- GNRC 1959
- RGEN 1981
- Country
- GNRC United States
- RGEN United States
- Employees
- GNRC N/A
- RGEN N/A
- Industry
- GNRC Metal Fabrications
- RGEN Medical/Dental Instruments
- Sector
- GNRC Consumer Discretionary
- RGEN Health Care
- Exchange
- GNRC Nasdaq
- RGEN Nasdaq
- Market Cap
- GNRC 9.7B
- RGEN 8.2B
- IPO Year
- GNRC 2010
- RGEN N/A
- Fundamental
- Price
- GNRC $143.57
- RGEN $136.22
- Analyst Decision
- GNRC Buy
- RGEN Buy
- Analyst Count
- GNRC 20
- RGEN 10
- Target Price
- GNRC $156.94
- RGEN $188.38
- AVG Volume (30 Days)
- GNRC 591.7K
- RGEN 772.8K
- Earning Date
- GNRC 07-31-2024
- RGEN 10-29-2024
- Dividend Yield
- GNRC N/A
- RGEN N/A
- EPS Growth
- GNRC 62.49
- RGEN N/A
- EPS
- GNRC 3.90
- RGEN N/A
- Revenue
- GNRC $4,021,807,000.00
- RGEN $602,354,000.00
- Revenue This Year
- GNRC $7.94
- RGEN $0.08
- Revenue Next Year
- GNRC $8.91
- RGEN $12.97
- P/E Ratio
- GNRC $36.77
- RGEN N/A
- Revenue Growth
- GNRC N/A
- RGEN N/A
- 52 Week Low
- GNRC $79.86
- RGEN $110.45
- 52 Week High
- GNRC $169.57
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- GNRC 45.20
- RGEN 37.10
- Support Level
- GNRC $139.66
- RGEN $138.80
- Resistance Level
- GNRC $143.61
- RGEN $150.72
- Average True Range (ATR)
- GNRC 4.32
- RGEN 5.27
- MACD
- GNRC -0.83
- RGEN -1.23
- Stochastic Oscillator
- GNRC 25.99
- RGEN 1.94
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.